A practical overview of the regulatory landscape for physicians, NPs, and PAs launching or running a medical weight management program.
Disclaimer: This page provides a general overview for educational purposes only and is not legal advice. Regulations vary by state and change frequently — always verify current requirements with your state medical board and a qualified healthcare attorney.
Adding a medical weight management program to your practice comes with real compliance responsibilities. From state licensing and scope-of-practice rules to GLP-1 prescribing regulations and telehealth restrictions, getting this right from the start protects both your patients and your practice.
The good news: the regulatory framework isn’t as complicated as it can seem, and most licensed physicians, NPs, and PAs are already well-positioned to launch compliantly. You just need to know where the key checkpoints are.
State Regulations & Licensing
Every state has its own rules governing medical weight management services. Before launching, confirm the following with your state medical board:
Practice Registration
Some states require a specific business registration for weight management clinics, separate from your existing medical practice license.
Physician Oversight Requirements
NPs and PAs must confirm their state’s supervision or collaboration agreement requirements before independently prescribing weight loss medications.
DEA Registration
Required if you plan to prescribe any controlled substances. Note: GLP-1 receptor agonists are not controlled substances.
Compounding Pharmacy Relationships
Your state board may have specific requirements around ordering from out-of-state 503A compounding pharmacies.
Where to look: Your state medical board website is the authoritative source. The Federation of State Medical Boards (fsmb.org) also maintains state-by-state licensing resources.
GLP-1 & Compounding Pharmacy Regulations
GLP-1 receptor agonists (semaglutide, tirzepatide) are FDA-approved medications. Branded versions (Ozempic®, Wegovy®, Mounjaro®, Zepbound®) require standard prescribing practices — no special licensing beyond your existing DEA registration and state medical license.
Compounded semaglutide and tirzepatide operate under a different framework. Compounding is regulated under two categories:
503A Pharmacies
Traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription. Permitted when a commercially available drug is on the FDA shortage list or when a patient has a documented need (e.g., allergy to an inactive ingredient).
503B Outsourcing Facilities
FDA-registered facilities that can produce larger volumes. Subject to stricter oversight but can compound without a patient-specific prescription.
What’s Changed Recently
The FDA removed semaglutide and tirzepatide from its drug shortage list in 2025, which has significantly changed the legal landscape for compounded versions. Enforcement timelines and state-level exceptions continue to evolve.
Staying current is the hard part.
Compounding regulations, FDA guidance, and state-level enforcement actions in this space are changing faster than any single webpage can track. IAPAM’s Certified Medical Weight Management Provider™ (CWMP) program includes ongoing compliance updates — so you get current regulatory guidance delivered to you, without having to monitor it yourself.
Learn About CWMP Certification →Staffing & Scope of Practice
Your team’s ability to perform specific tasks — patient intake, medication administration, monitoring, counseling — depends on their licensure and your state’s scope-of-practice rules.
Physicians (MD/DO)
Full prescribing authority in all states; can supervise all clinical staff.
Nurse Practitioners (NP)
Prescribing authority varies by state; some states require a physician collaboration agreement for Schedule III–V controlled substances.
Physician Assistants (PA)
Similar to NPs; state-dependent supervision and prescribing requirements.
RNs and MAs
Can administer injections under order, perform patient education, conduct follow-up check-ins. Cannot prescribe.
Non-Clinical Staff
Can handle scheduling, intake forms, payment. Cannot provide clinical advice or administer treatments.
All clinical staff involved in your weight management program should receive consistent training on your protocols, documentation standards, and patient safety procedures.
Telehealth Prescribing
Telehealth weight management is a significant and growing opportunity — but it comes with an added layer of regulatory complexity.
State Licensure
You must be licensed in the state where the patient is physically located at the time of the visit, with limited exceptions.
Prescribing via Telehealth
Most states permit prescribing GLP-1 medications via telehealth after a proper evaluation. Confirm your state’s requirements for establishing a valid patient-provider relationship.
Ryan Haight Act
Federal law requires an in-person evaluation before prescribing controlled substances via telehealth. GLP-1s are not affected by this requirement.
Interstate Medical Licensure Compact
The IMLC can streamline multi-state licensing if you plan to expand your telehealth reach.
For a deeper look at launching a telehealth weight management program, see our dedicated guide: How to Start a Telehealth Medical Weight Management Practice →
Patient Education & Documentation
The FDA requires that prescription weight loss treatments be accompanied by a food and fitness plan. This isn’t optional — it’s a compliance requirement, and it also happens to be what drives better patient outcomes.
Your practice should have documented processes for:
Initial Patient Intake
Medical history, current medications, contraindications screening.
Informed Consent
Specific to the medications and protocols you’re using.
Dietary & Lifestyle Counseling
The ketogenic and intermittent fasting protocols in the IAPAM Clean Start Weight Loss® program satisfy this requirement.
Ongoing Monitoring
Documented follow-up visits, weight and lab tracking, adverse event reporting.
Maintenance Planning
What happens when a patient reaches goal weight.
Proper documentation protects you medically and legally. → FDA’s Requirement for a Food and Fitness Plan — What It Means for Your Practice
Explore the Regulations Hub
Go deeper on the regulatory topics most relevant to your practice.
FDA Food & Fitness Plan Mandate
What the FDA’s requirement for a food and fitness plan means for your practice — and how to build a compliant program your patients can actually stick to.
Read Guide →GLP-1 Prescribing & Compounding Regulations
A closer look at the regulatory framework for semaglutide and tirzepatide — branded vs. compounded, 503A vs. 503B, and what the recent FDA shortage list changes mean for your practice.
Read Guide →Stay Ahead of the Regulations
The regulatory environment for medical weight management — especially GLP-1 prescribing and compounding — is changing faster than most practices can track. The IAPAM’s Certified Medical Weight Management Provider™ (CWMP) program gives you the clinical training and the ongoing compliance support to run a confident, compliant practice.
Ready to get certified?
Get the clinical training and ongoing compliance updates to run a confident, compliant GLP-1 practice.
Get CWMP Certified →New to medical weight management?
Start with our free 1 CME GLP-1 training — no commitment required.
Claim Your Free CME Training →Questions? Call 1-866-211-6901